Photokeratoconjunctivitis is a serious eye condition that affects millions of people worldwide. It is characterized by inflammation of the cornea and conjunctiva, and is often accompanied by the presence of light-sensitive cells in the eye. In severe cases, it can cause permanent vision loss. In this article, we will explore the causes and treatments of photokeratoconjunctivitis, so that doctors can better understand and diagnose this condition.
Photokeratoconjunctivitis, also known as PKC, is an inflammatory condition of the cornea and conjunctiva that is caused by exposure to ultraviolet (UV) light. It is most commonly caused by overexposure to sunlight, but can also be caused by exposure to artificial UV light sources, such as tanning beds. Symptoms of PKC include redness, swelling, and pain in the eyes. In severe cases, it can lead to vision loss.
The primary cause of photokeratoconjunctivitis is overexposure to UV light. This can be from either direct sunlight or artificial sources, such as tanning beds. People who work outdoors, such as farmers and construction workers, are particularly at risk for this condition. In addition, people who wear contact lenses are more susceptible to PKC, as the lenses can filter out some of the UV light.
Anyone who is exposed to excessive amounts of UV light is at risk for developing photokeratoconjunctivitis. This includes people who spend a lot of time outside, such as farmers and construction workers, as well as people who use tanning beds. Additionally, people who wear contact lenses are more susceptible to PKC, as the lenses can filter out some of the UV light.
If a doctor suspects that a patient has photokeratoconjunctivitis, they will typically begin by performing a physical exam of the eyes. They will look for signs of inflammation, such as redness and swelling, as well as any light-sensitive cells that may be present. The doctor may also order a corneal topography test to assess the shape and thickness of the cornea.
The primary goal of treatment for photokeratoconjunctivitis is to reduce inflammation and prevent vision loss. The doctor may prescribe topical corticosteroids to reduce the inflammation, as well as artificial tears to lubricate the eyes. In more severe cases, the doctor may recommend a corneal transplant to replace the damaged cornea.
The best way to prevent photokeratoconjunctivitis is to limit exposure to UV light. This can be done by wearing sunglasses or a wide-brimmed hat when outdoors, as well as avoiding tanning beds.
Photokeratoconjunctivitis is a serious eye condition that can lead to permanent vision loss. It is caused by overexposure to UV light, and is most commonly seen in people who work outdoors or use tanning beds. If a doctor suspects that a patient has this condition, they will typically begin by performing a physical exam of the eyes and may order a corneal topography test. Treatment for photokeratoconjunctivitis typically involves topical corticosteroids and artificial tears, and in more severe cases, a corneal transplant may be necessary.
1.
Q&A: When will individuals be able to receive customized cancer vaccines?
2.
Canadian Group Calls for Earlier Colorectal Cancer Screening
3.
Children living near oil and gas wells face higher risk of rare leukemia, studies show
4.
Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.
5.
Talquetamab Combos Show Survival Benefit in r/r Myeloma
1.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
2.
Clinical Pharmacology of Megakaryocyte Maturation-Targeted Therapeutics
3.
The Benefits and Side Effects of Bortezomib in the Fight Against Cancer
4.
Personalized Tumor Ecological Landscapes in Oncology
5.
Unmasking the Subtle Symptoms of Colon Cancer
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
3.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Immunotherapy: A New Era in Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation